10.1523/JNEUROSCI.2904-18.2019 Summary Keywords depression, anxiety, glucagon-like peptide-1 receptor agonist, diabetes, neuroendocrine Citation Tsai W-H, Sung F-C, Chiu L-T, Shih Y-H, Tsai M-C and Wu S-I (2022) Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study
Silybin dihemisuccinate protects rat erythrocytes against phenylhydrazine-induced lipid peroxidation and haemolysis
The lysates were incubated with Biotin-BPC157 at 4 C for 12 h, followed by incubation with anti-FBXO22 antibody at 4 C for 12 h
Varenicline decreases alcohol consumption in heavy-drinking smokers
This can cause discomfort and tenderness
The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial